Literature DB >> 27048433

Smokeless tobacco use in Sweden and other 17 European countries.

Maria E Leon1, Alessandra Lugo2, Paolo Boffetta3, Anna Gilmore4, Hana Ross5, Joachim Schüz6, Carlo La Vecchia7, Silvano Gallus2.   

Abstract

INTRODUCTION: The purpose of this study is to report prevalence and determinants of use of smokeless tobacco in a representative sample of men and women from Sweden, where Swedish snus sales are legal, and from 17 other European countries, where sales of smokeless tobacco are restricted.
METHODS: In 2010, a face-to-face survey including information on current smokeless tobacco use was conducted in a representative sample of around 1000 individuals aged ≥15 years per country in Albania, Austria, Bulgaria, Czech Republic, Croatia, England, Finland, France, Greece, Hungary, Ireland, Italy, Latvia, Poland, Portugal, Romania, Spain and Sweden.
RESULTS: In Sweden, the overall prevalence of smokeless tobacco use was 12.3% (20.7% in men, 3.5% in women). The corresponding estimate for other European countries combined was 1.1% (1.2% in men, 1.1% in women). Compared with never smokers, former smokers in Sweden were significantly more likely to use smokeless tobacco (odds ratio, OR: 2.67), whereas no difference in use was observed in other countries (OR: 1.04). Use of smokeless tobacco was similar among current smokers in Sweden (OR: 1.96) and in other countries (OR: 2.40) when contrasted to never smokers. In Sweden there were no differences in the number of cigarettes/day between smokers who also use smokeless tobacco (13.3 cigarettes/day) and exclusive cigarette smokers (12.9 cigarettes/day; P = 0.785).
CONCLUSIONS: Excluding Sweden, current oral tobacco use was not commonly reported in the European countries surveyed and was similarly rare both in men and in women. In Sweden, however, use of smokeless tobacco was about 10-fold higher than the rest of Europe and more prevalent in men than in women.
© The Author 2016. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27048433     DOI: 10.1093/eurpub/ckw032

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  12 in total

1.  Tobacco and electronic cigarette products: awareness, cessation attitudes, and behaviours among general practitioners.

Authors:  Faraz Mughal; Ahmed Rashid; Mohammed Jawad
Journal:  Prim Health Care Res Dev       Date:  2018-06-08       Impact factor: 1.458

2.  Use of Tobacco and Nicotine Products among Young People in Denmark-Status in Single and Dual Use.

Authors:  Lotus Sofie Bast; Marie Borring Klitgaard; Simone Gad Kjeld; Nanna Schneekloth Jarlstrup; Anne Illemann Christensen
Journal:  Int J Environ Res Public Health       Date:  2022-05-05       Impact factor: 4.614

3.  Cue salience of the use of an electronic nicotine delivery system (ENDS) device marketed to women.

Authors:  Ashley Vena; Krista Miloslavich; Dingcai Cao; Andrea King
Journal:  Addict Behav       Date:  2019-09-03       Impact factor: 3.913

4.  Key Drivers to Implement an Evidence-based Tobacco Control Programme in Schools of India: A Mixed-Methods Study.

Authors:  Akash Pradhan; Kunal Oswal; Keyuri Adhikari; Ajita Singh; Rishav Kanodia; Lakshman Sethuraman; Ramachandran Venkataramanan; Glorian Sorensen; Eve Nagler; Mangesh Pednekar; Prakash Gupta; Arnie Purushotham
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

5.  A Preliminary Investigation on Smokeless Tobacco Use and Its Cognitive Effects Among Athletes.

Authors:  Thomas Zandonai; Cristiano Chiamulera; Alberto Mancabelli; Danilo Falconieri; Marco Diana
Journal:  Front Pharmacol       Date:  2018-03-12       Impact factor: 5.810

6.  Stopping when knowing: use of snus and nicotine during pregnancy in Scandinavia.

Authors:  Ina Kreyberg; Karen E S Bains; Kai-H Carlsen; Berit Granum; Hrefna K Gudmundsdóttir; Guttorm Haugen; Gunilla Hedlin; Katarina Hilde; Christine M Jonassen; Live S Nordhagen; Björn Nordlund; Katrine D Sjøborg; Håvard O Skjerven; Anne C Staff; Cilla Söderhäll; Riyas M Vettukatil; Karin C Lødrup Carlsen
Journal:  ERJ Open Res       Date:  2019-04-08

7.  Otorhinolaryngological symptoms among smokeless tobacco (Maras powder) users.

Authors:  Saime Sagiroglu; Aysegul Erdogan; Adem Doganer; Ramazan Azim Okyay
Journal:  North Clin Istanb       Date:  2018-08-08

8.  Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.

Authors: 
Journal:  Lancet Public Health       Date:  2021-05-28

9.  COVID-19 among young adults in Sweden: self-reported long-term symptoms and associated factors.

Authors:  Sandra Ekström; Niklas Andersson; Alexandra Lövquist; André Lauber; Antonios Georgelis; Inger Kull; Erik Melén; Anna Bergström
Journal:  Scand J Public Health       Date:  2021-06-19       Impact factor: 3.021

10.  Identification of biomarkers specific to five different nicotine product user groups: Study protocol of a controlled clinical trial.

Authors:  Filip Sibul; Therese Burkhardt; Alpeshkumar Kachhadia; Fabian Pilz; Gerhard Scherer; Max Scherer; Nikola Pluym
Journal:  Contemp Clin Trials Commun       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.